BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24604720)

  • 1. Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation.
    Terada N; Shiraishi T; Zeng Y; Aw-Yong KM; Mooney SM; Liu Z; Takahashi S; Luo J; Lupold SE; Kulkarni P; Getzenberg RH
    J Cell Biochem; 2014 Sep; 115(9):1505-15. PubMed ID: 24604720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation.
    Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J
    Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
    Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
    Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling.
    Delury C; Hart C; Brown M; Clarke N; Parkin E
    Biochem Biophys Res Commun; 2016 Mar; 472(1):255-61. PubMed ID: 26921446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.
    Liu MX; Siu MK; Liu SS; Yam JW; Ngan HY; Chan DW
    Oncotarget; 2014 Feb; 5(4):944-58. PubMed ID: 24659709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
    Sun T; Wang Q; Balk S; Brown M; Lee GS; Kantoff P
    Cancer Res; 2009 Apr; 69(8):3356-63. PubMed ID: 19351832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C; Yinghao S; Li J
    Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
    Sun HW; Wu C; Tan HY; Wang QS
    Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.
    Patel BJ; Pantuck AJ; Zisman A; Tsui KH; Paik SH; Caliliw R; Sheriff S; Wu L; deKernion JB; Tso CL; Belldegrun AS
    J Urol; 2000 Oct; 164(4):1420-5. PubMed ID: 10992426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.
    Yan L; Xing Z; Guo Z; Fang Z; Jiao W; Guo X; Xu Z; Fang Z; Liu Z
    PLoS One; 2013; 8(2):e55790. PubMed ID: 23409045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
    Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
    Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
    Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
    Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.
    Chang WH; Ho BC; Hsiao YJ; Chen JS; Yeh CH; Chen HY; Chang GC; Su KY; Yu SL
    PLoS One; 2016; 11(3):e0150355. PubMed ID: 26930648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
    Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
    Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.